Kopp Family Office, LLC
In its 13F for Q4 2025 (holdings as of December 31, 2025, filed January 12, 2026), Kopp Family Office, LLC reported 21 stock positions worth $156.7 million. Its top holding was Vanguard Ftse Developed ETF (VEA) at 18.7% of the portfolio, followed by Invesco S&P 500 Equal Weight (RSP, 13.1%) and iShares Core S&P Midcap ETF (IJH, 11.7%). Compared with Q3 2025, it sold out of 5, added to 4 and reduced 13. The biggest buy was iShares Core S&P Midcap ETF (IJH, shares +51%) and the biggest sale an exit from FIVE9 (FIVN).
- Most Recent 13F
- Q2 2026
- Location
- MINNETONKA, MN
- CIK
- 0001683689
- Portfolio Value
- $156.7M (Q4 2025)
- SEC Filing
- 0000892712-26-000037 ↗ filed Jan 12, 2026
Holdings Value
Holdings 21 stocks · $156.7M
| VEA Vanguard Ftse Developed ETF | 18.69% | 468,604 | $29.3M | Reduce -4.9% |
| RSP Invesco S&P 500 Equal Weight | 13.15% | 107,516 | $20.6M | Add +35.2% |
| IJH iShares Core S&P Midcap ETF | 11.73% | 278,499 | $18.4M | Add +51.1% |
| VWO Vanguard Ftse Emerging Marke | 11.25% | 327,927 | $17.6M | Reduce -5.3% |
| AGG iShares Core U.S. Aggregate | 11.05% | 173,360 | $17.3M | Add +50.0% |
| XMTR Xometry Inc. Class A | 4.52% | 118,991 | $7.1M | Reduce -12.0% |
| ATEC Alphatec Holdings Inc. | 4.41% | 328,680 | $6.9M | Reduce -10.0% |
| VCEL Vericel Corp. | 3.72% | 161,655 | $5.8M | Reduce -6.4% |
| VRDN Viridian Therapeutics Inc. | 3.44% | 173,173 | $5.4M | Reduce -10.7% |
| WK Workiva Inc. | 3.08% | 55,866 | $4.8M | Reduce -3.0% |
| NTNX Nutanix Inc. Class A | 2.90% | 87,941 | $4.5M | Reduce -4.4% |
| MSFT Microsoft Corp. | 2.61% | 8,470 | $4.1M | Add +26.0% |
| TEAM Atlassian Corp. Class A | 2.61% | 25,249 | $4.1M | Reduce -3.6% |
| HWKN Hawkins Inc. | 2.47% | 27,288 | $3.9M | Reduce -4.7% |
| TCMD Tactile Systems Technology I | 2.36% | 127,329 | $3.7M | Reduce -6.1% |
| MANH Manhattan Associates Inc. | 1.81% | 16,330 | $2.8M | Reduce -3.6% |
| ISTB iShares Core 1-5 Year Usd Bo | 0.07% | 2,173 | $106K | No change |
| IVV iShares Core S&P 500 ETF | 0.06% | 147 | $101K | Reduce -7.5% |
| IAGG iShares Intl Aggregate Bond | 0.03% | 839 | $42K | No change |
| IMTB iShares Core 5-10 Year Usd | 0.03% | 911 | $40K | No change |
| IJR iShares Core S&P Small-Cap E | 0.01% | 141 | $17K | No change |
Portfolio Sells Q3 2025 → Q4 2025
| FIVN FIVE9 Inc. | Sold out | 0.00% | −4.71 |
| NEO Neogenomics Inc. | Sold out | 0.00% | −2.33 |
| INSP Inspire Medical Systems Inc. | Sold out | 0.00% | −1.96 |
| NTNX Nutanix Inc. Class A | Reduce -4.4% | 2.90% | −1.55 |
| VWO Vanguard Ftse Emerging Marke | Reduce -5.3% | 11.25% | −0.95 |
| HWKN Hawkins Inc. | Reduce -4.7% | 2.47% | −0.93 |
| VEA Vanguard Ftse Developed ETF | Reduce -4.9% | 18.69% | −0.53 |
| MANH Manhattan Associates Inc. | Reduce -3.6% | 1.81% | −0.45 |
| XMTR Xometry Inc. Class A | Reduce -12.0% | 4.52% | −0.28 |
| WK Workiva Inc. | Reduce -3.0% | 3.08% | −0.15 |
| TEAM Atlassian Corp. Class A | Reduce -3.6% | 2.61% | −0.11 |
| IEFA iShares Core MSCI Eafe ETF | Sold out | 0.00% | −0.08 |
| IEMG iShares Core MSCI Emerging | Sold out | 0.00% | −0.05 |
| IVV iShares Core S&P 500 ETF | Reduce -7.5% | 0.06% | −0.01 |
| VCEL Vericel Corp. | Reduce -6.4% | 3.72% | +0.18 |
| VRDN Viridian Therapeutics Inc. | Reduce -10.7% | 3.44% | +0.72 |
| ATEC Alphatec Holdings Inc. | Reduce -10.0% | 4.41% | +0.96 |
| TCMD Tactile Systems Technology I | Reduce -6.1% | 2.36% | +1.14 |
Portfolio Buys Q3 2025 → Q4 2025
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 29 | $163.2M | AGG, VEA, RSP, SPY, VWO |
| Q1 2026 | 21 | $145.3M | VEA, AGG, RSP, SPY, VWO |
| Q4 2025 | 21 | $156.7M | VEA, RSP, IJH, VWO, AGG |
| Q3 2025 | 26 | $153.6M | VEA, VWO, RSP, IJH, AGG |
| Q2 2025 | 27 | $154.5M | VEA, VWO, RSP, AGG, IJH |
| Q1 2025 | 28 | $144.7M | VEA, VWO, AGG, FIVN, WK |
| Q4 2024 | 21 | $157.8M | VEA, VWO, VCEL, NEO, FIVN |
| Q3 2024 | 22 | $157.0M | VEA, VWO, VCEL, NEO, FIVN |
| Q2 2024 | 21 | $161.2M | VEA, IWM, VCEL, VWO, FIVN |
| Q1 2024 | 21 | $175.1M | VEA, IWM, VCEL, VWO, FIVN |